Abstract:It has long believed that green tea has many health benefits. However, the clinical research has not provided conclusive evidence on these benefits especially on cancer prevention and treatment. In basic research, there are also many inconsistent reports on the biological activity of green tea extract and its major chemical components (catechins) with both inhibitory and stimulatory effects of EGCG on various cancer cells being reported. The stimulatory or inhibitory activity is often linked to either activation or inactivation of receptor tyrosine kinase. In this study, we present evidence that green tea extract and its major chemical components, Epigallocatechin-3-gallate (EGCG), epigallocatechin (ECG), and epicatechin (EC) inhibit growth of two human myeloid leukemia cells (TF-1a and MV4-11) through the regulation of pRb synthesis and pRb-E2F complexes. Addition of green tea extract to the culture of the myeloid leukemia cells significantly inhibited their proliferation with a substantial portion of cell death and decreased their colony forming cells in soft-agar culture. EGCG, ECG, and EC showed a similar inhibitory effect on these cells with the inhibitory efficiency varied with each catechin and the dose applied. Green tea extract and EGCG had no significant effect on the expression of G1 CDKs and the CDK inhibitors but downregulated the formation of pRb-CDKs examined by Western blot and immunoprecipitation, respectively. Surprisingly, the expression of pRb was markedly upregulated while the phosphorylation of pRb downregulated. The upregulation of pRb was blocked by pre-treatment with cycloheximide, a protein synthesis inhibitor, suggesting a requirement of protein synthesis. In agreement with these results, pRb-E2F complexes were upregulated and E2F DNA binding activity decreased determined by EMSA assay. Since both TF-1a and MV4-11 cell are factor-independent cell lines, the upregulation of pRb-E2F complexes and downregulation of DNA binding activity by green tea extract is most likely through a receptor tyrosine kinase-independent pathway. In summary, this study reveals that green tea extract, EGCG, ECG, and EC inhibited growth in human myeloid leukemia cells via regulating pRb synthesis and the formation of pRb-E2F complexes, leading to the inhibition of the E2F DNA binding activity. In addition, we found that that the stem/progenitor cells derived from the leukemia cell lines tested are more sensitive to the inhibitory effect of green tea extract. We propose that as a beverage one should not consume high amounts of green tea (extract) due to its possible cytotoxic or apoptotic effect, and its significant inhibitory effect on stem/progenitor cells, although the biological effect of green tea extract in vivo could be quite different from in vitro. However, the concentrated green tea extract may have potential for clinical investigation as an inducer of cancer cell death.Citation Format: Darrell Henry, Sebastien Brumaire, Gabriela Alvarez, Beatriz Alvarez, Xiaotang Hu. Involvement of pRb-E2F pathway in green tea extract-induced growth inhibition of human myeloid leukemia cells [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 209A.

Green tea polyphenol EGCG causes anti-cancerous epigenetic modulations in acute promyelocytic leukemia cells

(–)-Epigallocatechin-3-gallate induces apoptosis and differentiation in leukaemia by targeting reactive oxygen species and PIN1

Catechins induced acute promyelocytic leukemia cell apoptosis and triggered PML-RARα oncoprotein degradation

Epigallocatechin Gallate-Β-lactoglobulin Nanoparticles Improve the Antitumor Activity of EGCG for Inducing Cancer Cell Apoptosis

Abstract 521: Anticancer mechanisms of epigallocatechin gallate revealed via cellular and molecular profiling

Abstract 209A: Involvement of Prb-E2f Pathway in Green Tea Extract-Induced Growth Inhibition of Human Myeloid Leukemia Cells

Tea Polyphenol (-)-epigallocatechin-3-gallate Inhibits DNA Methyltransferase and Reactivates Methylation-Silenced Genes in Cancer Cell Lines.

Suppressive Effects of EGCG on Cervical Cancer

The Epigenetic Modification of Epigallocatechin Gallate (EGCG) on Cancer

(-)-Epigallocatechin-3-gallate Induces Non-Apoptotic Cell Death in Human Cancer Cells Via Ros-Mediated Lysosomal Membrane Permeabilization

Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications

EGCG inhibits proliferation, invasiveness and tumor growth by up-regulation of adhesion molecules, suppression of gelatinases activity, and induction of apoptosis in nasopharyngeal carcinoma cells

Tea polyphenol EGCG inhibited colorectal-cancer-cell proliferation and migration via downregulation of STAT3

Epigallocatechin Gallate Inhibits the Growth of Human Lung Cancer by Directly Targeting the EGFR Signaling Pathway.

Rb may play a key role in green tea-induced growth inhibition of human myeloid leukemia cells

Green Tea Polyphenols As a Natural Tumour Cell Proteasome Inhibitor.

Epigallocatechin Gallate (EGCG) Is the Most Effective Cancer Chemopreventive Polyphenol in Green Tea

Effect of Tea Polyphenols and EGCG on Nasopharyngeal Carcinoma Cell Proliferation and the Mechanisms Involved

Epigallocatechin-3-gallate and BIX-01294 have different impact on epigenetics and senescence modulation in acute and chronic myeloid leukemia cells

Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian Cancers

The Inhibitory Effect of (−)-Epigallocatechin-3-Gallate on Breast Cancer Progression via Reducing SCUBE2 Methylation and DNMT Activity